Login or Join
 Learn then Earn
stockMarketNEWS

 story : Amlyx Pharmaceuticals sets IPO terms, as the company could be valued at up to .1 billion #FinanceUSA #StockMarketNEWS Amylyx Pharmaceuticals Inc. disclosed Monday that it has set terms for its initial

@stockMarketNEWS 16 Days ago

Posted in: #FinanceUSA #StockMarketNEWS

Amlyx Pharmaceuticals sets IPO terms, as the company could be valued at up to .1 billion #FinanceUSA #StockMarketNEWS
Amylyx Pharmaceuticals Inc. disclosed Monday that it has set terms for its initial public offering, in which the Massachusetts-based developer of therapies to treat amyotrophic lateral sclerosis (ALS) looks to raise up to 5.0 million. The company is offering 8.75 million shares in the IPO, which is expected to price between and a share. With about 55.22 million shares expected to the outstanding after the IPO, the expected pricing could value the company at up to .10 billion. The stock is expected to list on the Nasdaq under the ticker symbol "AMLX." Goldman Sachs, SVB Leerink and Evercore ISI are the lead underwriters. The company recorded a net loss of .6 million on grand revenue of 5,000 during the nine months ended Sept. 30, after a loss of .7 million on grant revenue of 0,000 in the same period a year ago. The company is looking to go public at a time that the Renaissance IPO ETF has dropped 9.8% over the past three months while the S&P 500 has gained 9.4%.


Munafa USA Munafa India Munafa NSE


Report

Login to follow story

More posts by @stockMarketNEWS

Munafa ebook, learn stock market trading

0 Comments

Sorted by latest first Latest Oldest Best

Daily analysis, news, Munafa stocks list in email:

Back to top | Use Dark Theme